1.99
SAB Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−23.5
FY23:
−25.1
FY24:
−34.3
FY25:
−44.8
Change from FY21 to FY25
millions USD
FY21:
−10.9
FY22:
−2.09
FY23:
−0.15
FY24:
−12.0
FY25:
−122
Change from FY21 to FY25
millions USD
FY21:
35.9
FY22:
1.05
FY23:
66.8
FY24:
−1.17
FY25:
168
millions USD
FY21:
26.9
FY22:
−24.5
FY23:
41.5
FY24:
−47.7
FY25:
1.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.96
FY22:
−25.6
FY23:
−25.3
FY24:
−34.6
FY25:
−45.7
All amounts in millions USD